988 - A Mental Health Lifeline
988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.
Studies Show: Vitamin B6 May Reduce Anxiety Symptoms
The family of B vitamins are integral in several cellular proccesses in the nervous system. GABA is known as the "calming" neurotransmitter.
Researchers at University of Reading in the UK conducted a double-blind study aimed to characterize the effects of high dosages of B6 or B12 on behavior associated with neural inhibition and excitation. 478 subjects who self-reported anxiety and/or depression were assessed before and after one month of lactose placebo, vitamin B6, or vitamin B12 supplementation. Screening tools include screen for adult anxiety related disorders (SCAARED as well as mood and feeligns questionaire (MFQ) to measure depression symptoms. Furthermore, subjects underwent different tasks measuring sensory perception and sensitivity. Data was collected in 5 phases over the course of 5 years. In conclusion, researchers confirmed that high dosage of vitamin B6 reduces anxiety symptoms.
Read more about the study here.
You Might Also Enjoy...
TMS and Its Wide Application
FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.
Study Supports the Use of Repetitive TMS for Treatment Resistant Depression
A study in France has found that 1 in 4 individuals may achieve remission for treatment resistant depression with repetitive TMS.
List of TMS Devices that Have Been Cleared by the FDA to Treat Major Depression
Here is a list of TMS devices currently cleared by the FDA to treat major depression.
TMS for Parkinson's Disease
Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.
SAINT Protocol Now Cleared by the FDA
Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).